complications of semaglutide Ozempic and Wegowy Side effects- Acorn Gastroenterology – Acorn Gastroenterology Patel it Like it is:

In September 2024 the BLA rolling submission process was completed and the BLA officially filed November 2024 with a PDUFA action date of September 5, 2025

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

This article reviews the potential benefits, risks, and evidence surrounding twice-weekly GLP-1 dosing strategies

Glucagon is a hormone that raises blood sugar, so reducing it can help improve glucose control

Animal studies for electron microscopy were approved by the Animal Welfare Committees at the Institute of Experimental Medicine of the Hungarian Academy of Sciences

For women interested in a comprehensive approach, combining GLP-1 therapy with hormone optimization may offer additional support for managing midlife metabolic changes